International Journal of Pharmaceutical Investigation logo
Article

Polyethylene glycolated PAMAM dendrimers-Efavirenz conjugates

1★, 1, 2★ Corresponding author

  1. 1Department of Pharmaceutics, Hindu College of Pharmacy, Acharya Nagarjuna University, Guntur, Andhra Pradesh, INDIA.
  2. 2School of Pharmacy, University College Sadaya International University, JalanMenara Gading, Kuala Lumpur, MALAYSIA.

CORRESPONDENCE

Suneela Pyreddy

Department of Pharmaceutics, Hindu College of Pharmacy, Acharya Nagarjuna University, Guntur, Andhra Pradesh, INDIA.

dineshclbaid@gmail.com

Volume 4, Issue 1 · pp. 15-18 · 2014 · DOI: 10.4103/2230-973X.127735

ABSTRACT

Aim: The preparation of novel PEGylated PAMAM (poly-amidoamine) dendrimers for delivery of anti-HIV drug Efavirenz is reported.Method and Materials: About 5.0 G PAMAM dendrimers are prepared by ethylene diamine core via Michael addition by divergent method. PEGylation is done by polyethylene glycol 600 using epichlorhydrin as linker. PEGylated 5.0 G PAMAM dendrimers loaded with Efavirenz (EFV) are evaluated for FTIR, DSC, SEM, drug release, and stability studies. Results and Conclusion: From the results it is proved that this method is less time consuming, inexpensive, and reproducible. Drug-release studies indicate, PEGylated 5.0 G PAMAM-EFV dendrimers have shown prolonged drugrelease property.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Pyreddy, S., Kumar, P. D., & Kumar, P. V. (2014). Polyethylene glycolated PAMAM dendrimers-Efavirenz conjugates. International Journal of Pharmaceutical Investigation, 4(1), 15-18. https://doi.org/10.4103/2230-973X.127735

    Copyright and licence

    © 2014 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0